Hiromi Ashino

472 total citations
10 papers, 385 citations indexed

About

Hiromi Ashino is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biotechnology. According to data from OpenAlex, Hiromi Ashino has authored 10 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Biotechnology. Recurrent topics in Hiromi Ashino's work include Angiogenesis and VEGF in Cancer (7 papers), Marine Sponges and Natural Products (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Hiromi Ashino is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Marine Sponges and Natural Products (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Hiromi Ashino collaborates with scholars based in Japan. Hiromi Ashino's co-authors include Mariko Shimamura, Tsutomu Oikawa, Yukio Yamamoto, Tadahiko Hazato, Ikuo Morita, Hiroyuki Tsuda, Masaaki Iigo, Shozo Yamamoto, Kei Yamamoto and Hiroyasu Tobe and has published in prestigious journals such as Biochemical and Biophysical Research Communications, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Hiromi Ashino

10 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiromi Ashino Japan	8	233	84	52	50	33	10	385
Jen‐Jie Lin Taiwan	13	263 1.1×	50 0.6×	37 0.7×	70 1.4×	34 1.0×	20	555
Liping Xie China	13	399 1.7×	85 1.0×	43 0.8×	161 3.2×	59 1.8×	37	637
Wang Wang China	12	228 1.0×	42 0.5×	18 0.3×	34 0.7×	46 1.4×	30	379
Rakesh Dachineni United States	10	138 0.6×	33 0.4×	28 0.5×	72 1.4×	50 1.5×	13	363
Lirui Sun China	12	163 0.7×	24 0.3×	55 1.1×	74 1.5×	58 1.8×	20	396
Jingmin Li China	11	280 1.2×	21 0.3×	33 0.6×	63 1.3×	33 1.0×	29	514
Ming‐Tsung Lai Taiwan	14	243 1.0×	25 0.3×	85 1.6×	78 1.6×	55 1.7×	23	519
Michitaka Numoto Japan	12	382 1.6×	39 0.5×	17 0.3×	82 1.6×	98 3.0×	15	622
Tülin Özkan Türkiye	12	212 0.9×	40 0.5×	25 0.5×	41 0.8×	59 1.8×	47	408
Zhaohai Pan China	12	251 1.1×	23 0.3×	52 1.0×	73 1.5×	52 1.6×	18	478

Countries citing papers authored by Hiromi Ashino

Since Specialization

Citations

This map shows the geographic impact of Hiromi Ashino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromi Ashino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromi Ashino more than expected).

Fields of papers citing papers by Hiromi Ashino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromi Ashino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromi Ashino. The network helps show where Hiromi Ashino may publish in the future.

Co-authorship network of co-authors of Hiromi Ashino

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromi Ashino. A scholar is included among the top collaborators of Hiromi Ashino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromi Ashino. Hiromi Ashino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Tsukamoto, Ikuko, Norikazu Sakakibara, Tokumi Maruyama, et al.. (2010). A novel nucleic acid analogue shows strong angiogenic activity. Biochemical and Biophysical Research Communications. 399(4). 699–704. 22 indexed citations

Oikawa, Tsutomu, Yasuhiro Igarashi, Mayumi Sato, et al.. (2006). Dipalmitoylation of radicicol results in improved efficacy against tumor growth and angiogenesis in vivo. Cancer Science. 98(2). 219–225. 7 indexed citations

Shimamura, Mariko, Soko Kasai, Hideko Nagasawa, et al.. (2006). Angiogenesis inhibition of arginine-rich dendrimers, TX-1943 and TX-1944, which mimic the surface structure of endostatin. Vascular Pharmacology. 45(3). e119–e119. 3 indexed citations

Shimamura, Mariko, Yukio Yamamoto, Hiromi Ashino, et al.. (2004). Bovine lactoferrin inhibits tumor‐induced angiogenesis. International Journal of Cancer. 111(1). 111–116. 84 indexed citations

Ashino, Hiromi, Mariko Shimamura, Hiroshi Nakajima, et al.. (2003). Novel Function of Ascorbic Acid as an Angiostatic Factor. Angiogenesis. 6(4). 259–269. 74 indexed citations

Shimamura, Mariko, Hideko Nagasawa, Hiromi Ashino, et al.. (2003). A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors. British Journal of Cancer. 88(2). 307–313. 24 indexed citations

Shimamura, Mariko, Tadahiko Hazato, Hiromi Ashino, et al.. (2001). Inhibition of Angiogenesis by Humulone, a Bitter Acid from Beer Hop. Biochemical and Biophysical Research Communications. 289(1). 220–224. 82 indexed citations

Oikawa, Tsutomu, Isao Okayasu, Hiromi Ashino, et al.. (1993). Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo. European Journal of Pharmacology. 249(1-2). 113–116. 39 indexed citations

Oikawa, Tsutomu, Hideki Ito, Hiromi Ashino, et al.. (1993). Radicol, a microbial cell differentiation modulator, inhibits in vivo angiogenesis. European Journal of Pharmacology. 241(2-3). 221–227. 39 indexed citations

10.

Oikawa, Tsutomu, Masami Hasegawa, Ikuo Morita, et al.. (1992). Effect of 15-deoxyspergualin, a microbial angiogenesis inhibitor, on the biological activities of bovine vascular endothelial cells. Anti-Cancer Drugs. 3(3). 293–300. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact